News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Researchers make breakthrough in understanding aggressive brain cancer


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 Researchers at Duke identified why brain tumor patients have such low t cell counts - as low as that of AIDs patients.  Now we just need to figure out how to use this information!


Posted on: 09/13/2018

Researchers make breakthrough in understanding aggressive brain cancer

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740